Contact Information
6290 Corporate Court Suite 201-C, Fort Myers, FL, FL 33919
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm
Service Setting
Outpatient
Outpatient detoxification
Outpatient day treatment/partial hospitalization
Intensive outpatient treatment
Outpatient methadone/buprenorphine or naltrexone treatment
Regular outpatient treatment
Type of Care
Substance use treatment
Detoxification
Co-Occurring disorders
Treatment Approaches
Substance use disorder counseling
Trauma-related counseling
Telemedicine/telehealth therapy
12-step facilitation
Age Groups Accepted
Young Adults
Adults
Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
Ancillary Services
Case management service
Social skills development
Assessment/Pre-treatment
Comprehensive substance use assessment
Interim services for clients
Outreach to persons in the community
Complete medical history/physical exam
Screening for tobacco use
Screening for substance use
Screening for mental disorders
Professional interventionist/educational consultant
Detoxification (medical withdrawal) Services
Alcohol Detoxification
Benzodiazepines Detoxification
Cocaine Detoxification
Methamphetamines detoxification
Opioids detoxification
Medication routinely used during detoxification
Education and Counseling Services
HIV or AIDS education, counseling, or support
Hepatitis education, counseling, or support
Health education services other than HIV/AIDS or hepatitis
Substance use disorder education
Smoking/vaping/tobacco cessation counseling
Individual counseling
Group counseling
Family counseling
Marital/couples counseling
External Opioid Medications Source
In-network prescribing entity
Other contracted prescribing entity
No formal relationship with prescribing entity
Facility Operation (e.g., Private, Public)
Private for-profit organization
Facility Smoking Policy
Smoking permitted in designated area
Facility Vaping Policy
Vaping permitted in designated area
Gender Accepted
Female
Male
License/Certification/Accreditation
The Joint Commission
Opioid Medications used in Treatment
Buprenorphine
Naltrexone
Payment/Insurance/Funding Accepted
Private health insurance
Cash or self-payment
Pharmacotherapies
Acamprosate (Campral®)
Disulfiram
Buprenorphine with naloxone
Naltrexone (oral)
Medications for Hepatitis C treatment
Lofexidine
Clonidine
Medications for pre-exposure to prophylaxis
Medication for mental disorders
Nicotine replacement
Non-nicotine smoking/tobacco cessation
Recovery Support Services
Mentoring/peer support
Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity
Other contracted prescribing entity
Testing
Breathalyzer or blood alcohol testing
Drug or alcohol urine screening
HIV testing
STD testing
TB screening
Metabolic syndrome monitoring
Testing for Hepatitis B (HBV)
Testing for Hepatitis C (HCV)
Transitional Services
Aftercare/continuing care
Discharge Planning
Naloxone and overdose education
Outcome follow-up after discharge
Type of Opioid Treatment
Buprenorphine detoxification
Prescribes buprenorphine
Prescribes naltrexone
Relapse prevention with naltrexone
Accepts clients using MAT but prescribed elsewhere
Lofexidine or Clonidine detoxification
Maintenance service with medically supervised withdrawal after stabilization
